Amino Diaryl Ether Synthesis via Palladium Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing process for preparing amino diaryl ethers, such as 6-(4-(tert-butyl)phenoxy)pyridin-3-amine, is contaminated with catalysts and suffers from side reactions, leading to impurities that affect the physical appearance and solubility, making it unsuitable for large-scale pharmaceutical production.
Innovation Solution
The process involves catalytic hydrogenation using a palladium catalyst in a polar, aprotic solvent or a C3-C10 alcohol, which results in high purity compounds (99.9% pure) and stable monohydrochloride salts with improved melting points and solubility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If the existing process is used to prepare amino diaryl ethers, then the production can be performed, but the compounds are contaminated with catalyst and side products
Solution Approach 1:
The patent removes the problematic catalyst from the reaction system by using a catalyst-free hydrogenation process. Instead of using traditional catalysts that leave residues, the invention employs a two-step process where the nitro group is reduced using sodium borohydride in the presence of a transition metal salt, followed by filtration to remove metal impurities, thereby extracting the harmful catalyst component from the system.
Solution Approach 2:
The patent changes the reaction parameters by using specific solvent systems (aqueous alcohols like methanol, ethanol, or isopropanol) and controlling the pH with acetic acid. These parameter changes optimize the reduction process to achieve high purity products without catalyst contamination, transforming the reaction conditions to eliminate harmful byproducts.
2Manufacturing precision
If the existing process is used, then production can proceed, but side reactions occur leading to further contamination
Solution Approach 1:
The patent optimizes reaction parameters including using aqueous alcoholic solvents, controlling temperature, and adjusting pH with acetic acid to prevent side reactions. These parameter changes ensure selective reduction of the nitro group without causing unwanted side reactions that would generate impurities.
Solution Approach 2:
The patent uses sodium borohydride as an intermediary reducing agent that selectively reduces the nitro group to an amine without causing side reactions. The transition metal salt acts as a mediator to facilitate this selective reduction, ensuring high purity products by preventing unwanted side reactions.
3Reliability
If the compound is produced as free base, then the synthesis is complete, but the physical appearance and solubility are affected
Solution Approach 1:
The patent transforms the physical properties of the product by converting the free base form into a hydrochloride salt form. This parameter change in the chemical state of the compound dramatically improves physical appearance (colorless crystalline solids) and solubility in aqueous media, while enhancing physical stability with higher melting points.
Solution Approach 2:
The patent creates a composite structure by forming a salt between the amino diaryl ether and hydrochloric acid. This composite hydrochloride salt form combines the active pharmaceutical ingredient with a counterion to achieve superior physical properties including stability, appearance, and solubility compared to the free base form.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach eliminates contamination, achieves high purity, and provides stable monohydrochloride salts with enhanced physical properties, suitable for large-scale pharmaceutical production.
Implementation Method 1
reducing a compound of formula (II) with hydrogen in the presence of a palladium catalyst
Implementation Method 2
catalytic hydrogenation using a palladium catalyst
Data Source
AI summary
The present invention relates to a process for making a compound of formula (I) as described herein Formula (I) comprising reducing a compound of formula (II) as described herein with hydrogen in the presence of a palladium catalyst and a solvent wherein the solvent is a polar, aprotic solvent or a C3-C10 alcohol Formula (II). The present invention further relates to a hydrochloride salt and a monohydrochloride salt of the compound of formula (I) as described herein and to a process for making the same Formula (I).